Cargando…
Lack of SARS-CoV-2-specific cellular response in critically ill COVID-19 patients despite apparent effective vaccination
Autores principales: | Bidar, Frank, Monneret, Guillaume, Berthier, Franck, Lukaszewicz, Anne-Claire, Venet, Fabienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176157/ https://www.ncbi.nlm.nih.gov/pubmed/35676693 http://dx.doi.org/10.1186/s13054-022-04038-5 |
Ejemplares similares
-
Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient
por: Monneret, Guillaume, et al.
Publicado: (2020) -
Association of pronounced elevation of NET formation and nucleosome biomarkers with mortality in patients with septic shock
por: Haem Rahimi, Muzhda, et al.
Publicado: (2023) -
A novel virotherapy encoding human interleukin-7 improves ex vivo T lymphocyte functions in immunosuppressed patients with septic shock and critically ill COVID-19
por: Crausaz, Morgane, et al.
Publicado: (2022) -
Persistently Elevated Soluble Triggering Receptor Expressed on Myeloid Cells 1 and Decreased Monocyte Human Leucocyte Antigen DR Expression Are Associated With Nosocomial Infections in Septic Shock Patients
por: Venet, Matthieu, et al.
Publicado: (2023) -
Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients
por: Bidar, Frank, et al.
Publicado: (2022)